APOA2 anticorps

N° du produit ABIN125992

Cet anticorps Souris Monoclonal détecte spécifiquement APOA2 dans . Il présente une réactivité envers Humain.

Aperçu rapide pour APOA2 anticorps (ABIN125992)

Antigène: APOA2 (Apolipoprotein A-II (APOA2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp APOA2 est non-conjugé

Application: Veuillez nous consulter SVP

Clone: M-32

Détail du produit anti-APOA2 anticorps

Specificité: Specific for Apo AII

Réactivité croisée (Details): Species reactivity (tested):Human.

Purification: Affinity Chromatography

Immunogène: Purified Human HDL.

Isotype: IgG2a

Information d'application

Restrictions: For Research Use only

Stockage

Reconstitution: Restore with dist. water

Buffer: PBS containing 0.5 % BSA as stabilizer and 0.09 % Sodium Azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide : a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: This product is photosensitive and should be protected from light

Stock: 4 °C

Stockage commentaire: Prior to and following reconstitution store the antibody at 2-8 °C. DO NOT FREEZE!

Détails sur APOA2

Antigène: APOA2 (Apolipoprotein A-II (APOA2))

Autre désignation: Apolipoprotein A II (Apo AII)

Sujet: Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles. The apolipoprotein A II gene consists of 4 exons and 3 introns. The four exons encode the 5' untranslated region, pre peptide, a short N terminal domain and a C terminal domain composed of a variable number of lipid binding amphipathic helices. Familial apolipoprotein A II deficiency may result from a splice junction alteration which blocks splicing of intron 3 from the primary transcript and result in the formation of a non functional mRNA.Synonyms: APOA2, Apo-AII, ApoA-II, Apolipoprotein A-II, Apolipoprotein A2

ID gène: 336

NCBI Accession: NP_001634

UniProt: P02652

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism